Epigenetic Reprogramming

Group leads: Pamela Kearns


The outputs from this research group flows from two interleaved streams of inquiry. One relates to virus induced epigenetic reprogramming, and focuses on the contribution of Human papillomavirus and Epstein Barr virus induced epigenetic changes to the pathogenesis of their associated malignancies. The other relates to the reprogramming which follows the use of epigenetic therapy, and focuses on patients with AML.


Pamela Kearns (group lead), Senior Lecturer in Paediatric Oncology 
S. Leonard 
Jennifer Anderton 
Wenbin Wei, Senior Bioinformatician 
Stuart Collins 
Naheema Gordon 
Ayaf Diyaf 
Merlin Pereira